3,4-methylenedioxyamphetamine has been researched along with Idiopathic Parkinson Disease in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lebsanft, HB | 1 |
| Mayerhofer, A | 1 |
| Kovar, KA | 1 |
| Schmidt, WJ | 1 |
| Torrisi, D | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram | 2003 |
My dad has Parkinson disease: and my mother has boundless love.
Topics: Activities of Daily Living; Adaptation, Psychological; Aged; Aged, 80 and over; Attitude to Health; | 2005 |